We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFE
2126
DELISTED
Safehold Inc.
SAFE
$33K ﹤0.01%
+1,084
New +$33K
ADAP
2127
DELISTED
Adaptimmune Therapeutics
ADAP
$32K ﹤0.01%
21,472
+21,372
+21,372% +$50K
ADMA icon
2128
ADMA Biologics
ADMA
$2.22B
$32K ﹤0.01%
7,346
-6,022
-45% -$25.2K
AMLP icon
2129
Alerian MLP ETF
AMLP
$12.8B
$32K ﹤0.01%
690
-717
-51% -$33.9K
APOG icon
2130
Apogee Enterprises
APOG
$908M
$32K ﹤0.01%
823
+733
+814% +$29K
ASX icon
2131
ASE Group
ASX
$82.2B
$32K ﹤0.01%
7,087
+6,550
+1,220% +$28.8K
BHP icon
2132
BHP
BHP
$230B
$32K ﹤0.01%
716
-4,480
-86% -$209K
CHX
2133
DELISTED
ChampionX
CHX
$32K ﹤0.01%
1,197
-46,702
-98% -$1.36M
CMP icon
2134
Compass Minerals
CMP
$1.15B
$32K ﹤0.01%
569
-3,866
-87% -$207K
CTRE icon
2135
CareTrust REIT
CTRE
$9.74B
$32K ﹤0.01%
1,377
-6,933
-83% -$163K
CXT icon
2136
Crane NXT
CXT
$3.07B
$32K ﹤0.01%
1,149
-1,097
-49% -$30.6K
DAKT icon
2137
Daktronics
DAKT
$1.04B
$32K ﹤0.01%
+4,283
New +$28.5K
DNLI icon
2138
Denali Therapeutics
DNLI
$3.97B
$32K ﹤0.01%
2,095
+1,980
+1,722% +$37.8K
EWK icon
2139
iShares MSCI Belgium ETF
EWK
$165M
$32K ﹤0.01%
1,688
+858
+103% +$16K
FCFS icon
2140
FirstCash
FCFS
$8.78B
$32K ﹤0.01%
346
-226
-40% -$22.4K
FSTA icon
2141
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$32K ﹤0.01%
878
-2,439
-74% -$87.6K
GFI icon
2142
Gold Fields
GFI
$36.5B
$32K ﹤0.01%
6,568
+6,344
+2,832% +$34.5K
GOLF icon
2143
Acushnet Holdings
GOLF
$5.45B
$32K ﹤0.01%
1,231
+1,197
+3,521% +$31.3K
JACK icon
2144
Jack in the Box
JACK
$335M
$32K ﹤0.01%
352
-43
-11% -$3.58K
JOUT icon
2145
Johnson Outdoors
JOUT
$505M
$32K ﹤0.01%
538
+402
+296% +$25.3K
KLIC icon
2146
Kulicke & Soffa
KLIC
$4.78B
$32K ﹤0.01%
1,344
-952
-41% -$20.9K
MBIO icon
2147
Mustang Bio
MBIO
$4.55M
$32K ﹤0.01%
+13
New +$35.6K
MD icon
2148
Pediatrix Medical
MD
$2.2B
$32K ﹤0.01%
1,408
+85
+6% +$1.94K
PHUN icon
2149
Phunware
PHUN
$43.6M
$32K ﹤0.01%
445
+167
+60% +$14.6K
PPBI
2150
DELISTED
Pacific Premier Bancorp
PPBI
$32K ﹤0.01%
1,022
-818
-44% -$24.9K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.